{"id":"W4297242573","doi":"10.1002/ijc.34304","title":"Survival outcomes of metastatic breast cancer patients by germline <i>BRCA1/2</i> status in a large multicenter real‐world database","year":2022,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Merck Sharp and Dohme; Genentech; AstraZeneca Pharma Poland; Servier; Eisai Canada; Genomic Health; Fondation ARC pour la Recherche sur le Cancer; Roche; Seagen; Gilead Sciences; Daiichi Sankyo Europe; European Commission; Sanofi; Fox Chase Cancer Center; Amgen; Pfizer; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company; Daiichi Sankyo Company; Clovis Oncology","keywords":"Internal medicine; Medicine; Germline; Oncology; Metastatic breast cancer; Breast cancer; Subgroup analysis; Overall survival; Cohort; Cancer; Confidence interval; Biology; Genetics; Gene","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001243061,0.0002288433,0.0005376365,0.0006806867,0.0002603031,0.0007128005,0.0005490761,0.0004304633,0.0008125795],"category_scores_gemma":[0.003078216,0.0002764914,0.0006181308,0.001440116,0.0002141728,0.0006146752,0.0006469171,0.0005015621,0.0001570035],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006479161,"about_ca_system_score_gemma":0.0003975374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006402574,"about_ca_topic_score_gemma":0.008621614,"domain_scores_codex":[0.9990053,0.0003539238,0.0001328451,0.0002926086,0.0001135074,0.0001019932],"domain_scores_gemma":[0.9978847,0.0004340306,0.001181061,0.0002026132,0.0001349576,0.0001626637],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006068862,0.00004000555,0.9965661,0.00002868443,0.0002540858,0.00008033577,0.00006325074,0.0001741584,0.0001527308,0.00002765068,0.0005414872,0.001464707],"study_design_scores_gemma":[0.0001199649,0.000146015,0.9966946,0.00002313629,0.0002027533,0.0005941811,0.0002951432,0.001074605,0.0001043846,0.00004832982,0.0006848152,0.00001210178],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973319,0.0003766612,0.00004572113,0.00007382363,0.000003270143,0.000007290245,0.002034715,0.000002837843,0.0001237183],"genre_scores_gemma":[0.996444,0.0001645624,0.00006956591,0.00005563182,0.000009524209,0.00001627193,0.003195109,0.000001924798,0.00004334086],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006402574,"threshold_uncertainty_score":0.01273066,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01111869465509451,"score_gpt":0.3326155914108866,"score_spread":0.3214968967557921,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}